Soluble gp130 is up-regulated in the implantation window and shows altered secretion in patients with primary unexplained infertility

Journal of Clinical Endocrinology and Metabolism

Volumn 87, Issue 8, 2002, Pages 3953-3960

  Sherwin, J R A ^a   Smith, S K ^a   Wilson, A ^a   Sharkey, A M ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN GP 130; INTERLEUKIN 11; INTERLEUKIN 6; INTERLEUKIN 6 RECEPTOR; LEUKEMIA INHIBITORY FACTOR;

ADULT; ARTICLE; CLINICAL ARTICLE; COMPLEX FORMATION; CONTROLLED STUDY; CYTOKINE RELEASE; ENDOMETRIUM BIOPSY; FEMALE; FEMALE INFERTILITY; GENE CONTROL; HUMAN; HUMAN TISSUE; IMMUNOLOCALIZATION; MENSTRUAL CYCLE; MENSTRUATION; NIDATION; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN FAMILY; PROTEIN LOCALIZATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

MAMMALIA;

EID: 0036345563     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jcem.87.8.8766     Document Type: Article

References (43)

1. Molecular interactions between embryo and uterus in the adhesion phase of human implantation
2. The signals and molecular pathways involved in implantation, a symbiotic interaction between blastocyst and endometrium involving adhesion and tissue invasion
3. Gp130 and the interleukin-6 family of cytokines
4. Structural design and molecular evolution of a cytokine receptor superfamily
5. Interleukin-6 triggers the association of its receptor with a possible signal transducer, gp130
6. Uterine expression of leukemia inhibitory factor coincides with the onset of blastocyst implantation
7. Blastocyst implantation depends on maternal expression of leukaemia inhibitory factor
8. Leukemia inhibitory factor can substitute for nidatory estrogen and is essential for inducing a receptive uterus for implantation but is not essential for subsequent embryogenesis
9. Infertility in female mice lacking the receptor for interleukin 11 is due to a defective uterine response to implantation
10. Leukaemia inhibitory factor mRNA concentration peaks in human endometrium at the time of implantation and the blastocyst contains mRNA for the receptor at this time
11. Modulation of leukemia inhibitory factor gene expression and protein biosynthesis in human endometrium
12. The production of leukaemia inhibitory factor by human endometrium: Presence in uterine flushings and production by cells in culture
13. Leukemia inhibitory factor (LIF) and LIF receptor expression in human endometrium suggests a potential autocrine/paracrine function in regulating embryo implantation
14. Leukaemia inhibitory factor in human endometrium throughout the menstrual cycle
15. In vitro endometrial secretion of human interleukin for DA cells/leukaemia inhibitory factor by explant cultures from fertile and infertile women
16. Endometrial leukemia inhibitory factor (LIF) as a possible cause of unexplained infertility and multiple failures of implantation
17. Progressive rise in the expression of interleukin-6 in human endometrium during menstrual cycle is initiated during the implantation window
18. Human endometrial interleukin-6 (IL-6): In vivo messenger ribonucleic acid expression, in vitro protein production, and stimulation thereof by IL-1 β
19. Interleukins-6 and -8 levels in sera and cervical mucus of fertile, idiopathic infertile, and immunoinfertile women: Implication in infertility
20. Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway
21. Soluble forms of the interleukin-6 signal-transducing receptor component gp130 in human serum possessing a potential to inhibit signals through membrane-anchored gp130
22. The soluble interleukin-6 receptor is generated by shedding
23. Identification and characterization of two distinct truncated forms of gp130 and a soluble form of leukemia inhibitory factor receptor α-chain in normal human urine and plasma
24. Differential shedding of the two subunits of the interleukin-6 receptor
25. LIF and OM directly interact with a soluble form of gp130, the IL-6 receptor signal transducing subunit
26. Cloning and expression of an alternatively spliced mRNA encoding a soluble form of the human interleukin-6 signal transducer gp130
27. Stage-specific expression of cytokine and receptor messenger ribonucleic acids in human preimplantation embryos
28. Cloning of novel soluble gp130 and detection of its neutralizing autoantibodies in rheumatoid arthritis
29. Dating the endometrial biopsy
30. Expression of mRNA for vascular endothelial growth factor in human placenta
31. Molecular cloning and expression of an IL-6 signal transducer, gp130
32. Cytokine pleiotropy and redundancy- gp130 cytokines in human implantation
33. Time of implantation of the conceptus and loss of pregnancy
34. Functional inhibition of hematopoietic and neurotrophic cytokines by blocking the interleukin 6 signal transducer gp130
35. Characterization of soluble gp130 released by melanoma cell lines: A polyvalent antagonist of cytokines from the interleukin 6 family
36. Leukemia inhibitory factor, leukemia inhibitory factor receptor, and glycoprotein 130 in rhesus monkey uterus during menstrual cycle and early pregnancy
37. Leukemia inhibitory factor (LIF) inhibits angiogenesis in vitro
38. Pattern of interleukin 6 gene expression in vivo suggests a role for this cytokine in angiogenesis
39. Production of hematopoietic regulatory factors in cultures of adult and fetal mouse organs: Measurement by specific bioassays
40. Dysregulated expression of ebaf, a novel molecular defect in the endometria of patients with infertility
41. Detection of ebaf, a novel human gene of the transforming growth factor β superfamily association of gene expression with endometrial bleeding
42. Integrins as markers of uterine receptivity in women with primary unexplained infertility
43. The endometrium as a novel target for leptin: Differences in fertility and subfertility